Home > Result Summaries: Compounds > SRT2379 Result Summaries: SRT2379 GSKStudy ID Phase Title Summary (Download) 114011 phase 1 A Phase I Randomized, Placebo-Controlled, Single-Blind, Multiple-Dose, Dose-Escalation Clinical Study to Assess the Safety and Pharmacokinetics of SRT2379 in Normal Healthy Male Volunteers (1 citation(s)) 115083 phase 1 A Phase I Study to Evaluate a Single Oral Dose of SRT2379 on the Endotoxin Induced Inflammatory Response in Healthy Male Subjects (0 citation(s))
